| Literature DB >> 32319961 |
Nick Haber1, Anish Nag2, Catalin Voss3, Serena Tamura4, Jena Daniels5, Jeffrey Ma6, Bryan Chiang6, Shasta Ramachandran6, Jessey Schwartz6, Terry Winograd3, Carl Feinstein6, Dennis P Wall6.
Abstract
BACKGROUND: Several studies have shown that facial attention differs in children with autism. Measuring eye gaze and emotion recognition in children with autism is challenging, as standard clinical assessments must be delivered in clinical settings by a trained clinician. Wearable technologies may be able to bring eye gaze and emotion recognition into natural social interactions and settings.Entities:
Keywords: artificial intelligence; autism spectrum disorder; digital therapy; eye tracking; machine learning; precision health; translational medicine; wearable technologies
Mesh:
Year: 2020 PMID: 32319961 PMCID: PMC7203617 DOI: 10.2196/13810
Source DB: PubMed Journal: J Med Internet Res ISSN: 1438-8871 Impact factor: 5.428
Cohort composition after excluding study failures. Medication/comorbidity surveys were not completed by 5 participants from the autism spectrum disorder cohort.
| Demographic and phenotypic characteristics | Autism spectrum disorder (N=16) | Neurotypical controls (N=17) | |
|
|
|
| |
|
| Males | 13 (81) | 9 (53) |
|
| Females | 3 (19) | 8 (47) |
| Age (years), mean (SD; range) | 12.13 (3.31; 6-17) | 11.53 (2.48; 8-17) | |
| Social Communication Questionnaire score, mean (SD; range) | 18.86 (6.43; 7-31) | 1.82 (1.07; 0-4) | |
| Abbreviated Battery Intelligence Quotient standard score, mean (SD; range) | 102.75 (19.54; 55-133) | 108.94 (9.58; 91-129) | |
| Social Responsiveness Scale Total score, mean (SD; range) | 78.85 (11.13; 58->90) | 44.41 (8.11; 36-64) | |
|
|
|
| |
|
| Anxiety disorder/depression | 1 (9)a | 0 (0) |
|
| Attention-deficit/hyperactivity disorder | 1 (9)a | 1 (5) |
|
|
|
| |
|
| Methylphenidate | 3 (27)a | 0 (0) |
|
| Arginine vasopressin | 1 (9)a | 0 (0) |
|
| Guanfacine extended release | 1 (9)a | 0 (0) |
|
| Sertraline | 2 (18)a | 0 (0) |
|
| Carbamazepine | 1 (9)a | 0 (0) |
|
| Aripiprazole | 1 (9)a | 0 (0) |
|
| Dexmethylphenidate | 1 (9)a | 0 (0) |
|
| Allergy medication (unspecified) | 0 (0)a | 1 (5) |
|
| Other (unspecified) | 0 (0)a | 1 (5) |
|
| No medication | 4 (36)a | 15 (88) |
aN=11.
Figure 1Study setup: (a) Study screen displaying facial affect stimuli and nonsocial distractors displayed for 6 seconds. (b) The screen displaying the list of emotions that the participant is asked to classify the face from. (c) A nonparticipant child wearing a Google Glass with a custom-built eye tracker fitted using a 3D-printed mount in a dry-run of the study protocol.
Figure 2A histogram of the distraction ratio of autism spectrum disorder (ASD; red) and neurotypical control (NC; blue) participants on a logarithmic scale. On average, the ASD group looked at facial stimuli for less time than NCs. However, there is also considerable overlap between the groups that reduces the predictiveness of gaze features in the individual diagnosis prediction task.
Figure 3Histograms of (N-frame excluding) distraction ratio deFLR(p,t) of autism spectrum disorder (red) and neurotypical control (blue) participants, averaged over participants and broken down by emotion.
Figure 4Cross-validation confusion matrices for the elastic net classifier trained on all features (pat, gaze, conf, and cm) for trials 1, 2, and 3, and features from all trials concatenated (accuracies in parenthesis). Autism spectrum disorder and neurotypical control participants are most distinguishable in trial 1, the first trial conducted which was before receiving any feedback or adjusting to the task. cm=Emotion confusion matrices; conf=Emotion confusion details; gaze=Gaze patterns; pat=Participant metadata.
Figure 5The shuffle test visualization for the elastic net classifier trained on all features (pat, gaze, conf, cm) concatenated for all trials yielding P=.05. cm=Emotion confusion matrices; conf=Emotion confusion details; gaze=Gaze patterns; pat=Participant metadata.
Classification accuracies and significance tests for the elastic net classifier trained on different feature combinations and trials. All shuffle tests were performed for 2500 iterations and checked for convergence.
| Data tested | All trials | Trial 1 | Trial 2 | Trial 3 | ||||
|
| Accuracy, % | Accuracy, % | Accuracy, % | Accuracy, % | ||||
| pata (baseline) | 71.0 | .04 | 71.0 | .04 | 71.0 | .04 | 71.0 | .04 |
| pat-gaze-cm-conf (full) | 71.0 | .05 | 74.2 | .03 | 54.8 | .24 | 61.3 | .17 |
| cmb | 67.7 | .08 | 67.7 | .09 | 6.5 | .998 | 35.5 | .81 |
| confc | 64.5 | .16 | 58.1 | .23 | 48.4 | .63 | 41.9 | .72 |
| cm-conf | 64.5 | .13 | 61.3 | .17 | 48.4 | .56 | 41.9 | .68 |
| gazed | 83.9 | .002 | 83.9 | .00 | 38.7 | .80 | 61.3 | .14 |
| gaze-conf | 83.9 | .004 | 80.6 | .01 | 51.6 | .34 | 61.3 | .17 |
| gaze-cm | 71.0 | .05 | 64.5 | .10 | 61.3 | .14 | 58.1 | .21 |
| gaze-cm-conf | 71.0 | .05 | 74.2 | .04 | 45.2 | .63 | 51.6 | .36 |
| pat-gaze | 77.4 | .02 | 71.0 | .04 | 67.7 | .09 | 74.2 | .03 |
| pat-gaze-cm | 71.0 | .05 | 64.5 | .11 | 67.7 | .08 | 64.5 | .11 |
| pat-gaze-conf | 74.2 | .04 | 67.7 | .11 | 35.5 | .85 | 64.5 | .14 |
| pat-cm | 58.1 | .21 | 54.8 | .25 | 67.7 | .09 | 61.3 | .16 |
| pat-conf | 64.5 | .14 | 61.3 | .19 | 64.5 | .13 | 51.6 | .35 |
| pat-cm-conf | 61.3 | .17 | 48.4 | .45 | 64.5 | .13 | 32.3 | .88 |
apat: participant metadata.
bcm: emotion confusion matrices.
cconf: emotion confusion details.
dgaze: gaze patterns.